Locametz -Kit for The Preparation of Gallium Ga 68 Gozetotide Injection

LOCAMETZ, after radiolabeling with gallium-68, is a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA)-positive lesions in men with prostate cancer: with suspected metastasis who are candidates for initial definitive therapy, with suspected recurrence based on elevated serum prostate-specific antigen (PSA) level. for selection of patients with metastatic prostate cancer, for whom, lutetium Lu 177 vipivotide tetraxetan PSMA-directed therapy is indicated.